American Biogenetic Sciences` New President Highlights Progress in 2000 and Business Outlook for 2001
(PR Newswire)...We expect to use this technology to find ways to improve the treatment of several types of solid tumors, such as breast, prostate, lung and colon cancers,......, an orally active small molecule drug that crosses the blood brain barrier and promotes nerve cell growth, is ABS` leading compound under development....- Feb 05 10:08 AM ET
IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source: http://biz.yahoo.com/prnews/010205/ny_america_2.html
(Everything below this line is from VirtualTrials.com!)
Click HERE to return to brain tumor news headlines